Dynamic 18F-FDG PET response to preoperative neoadjuvant chemotherapy in potentially resectable pancreatic ductal adenocarcinoma may predict overall survival

J Kim, J Miller-Ocuin, A Rahmim, M Oborski, C Laymon… - 2017 - Soc Nuclear Med
498 Objectives: Dynamic PET, combined with kinetic parameter modeling, enables valuable
quantification of tumor blood flow (early uptake) and metabolism (late uptake). In this work …

Value of preoperative F-18 FDG PET/CT in predicting recurrence patterns and survival after curative surgical resection in pancreatic ductal adenocarcinoma

N Lee, S Kim, J Cha, SH Hwang, C Arthur, WJ Kang… - 2016 - Soc Nuclear Med
1599 Objectives To evaluate the prognostic value of preoperative F-18 FDG PET in patients
with pancreatic ductal adenocarcinoma. Methods From Aug 2006 to Dec 2014, patients with …

Value of FDG PET/CT in early response assessment of neoadjuvant chemotherapy for patients with pancreatic adenocarcinoma

K Grant, J Miller, M Lotze, N Bahary, A Singhi… - 2016 - Soc Nuclear Med
1598 Objectives To evaluate the prognostic value of FDG PET/CT in the early response
assessment of randomized neoadjuvant chemotherapy (gemcitabine and Nab-paclitaxel …

Preoperative 18-FDG PET predicts survival in resectable pancreatic cancer

V Beltrame, M Gruppo, S Merigliano, S Bissoli… - European Journal of …, 2015 - ejso.com
Study objective: The identification of prognostic factors useful in selecting patients with
pancreatic cancer who will benefit from surgery or other treatments, is still being debated …

Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy

N Ikenaga, K Nakata, M Hayashi, S Nakamura… - Journal of …, 2023 - Elsevier
Purpose To evaluate the clinical significance of 18 F-fluorodeoxyglucose positron emission
tomography/computed tomography in patients with pancreatic ductal adenocarcinoma who …

Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-fluoro-2-deoxy-d-glucose positron-emission …

K Tabata, A Nishie, Y Shimomura, T Isoda, Y Kitamura… - Clinical Radiology, 2022 - Elsevier
AIM To determine whether the pathological response to preoperative chemotherapy for
pancreatic ductal adenocarcinoma (PDAC) can be predicted using 2-[18 F]-fluoro-2-deoxy-d …

Relationship between metabolic response on integrated time-of-flight FDG PET/MRI and pathologic treatment response in patients with FDG-avid borderline …

I Garg, N Samreen, J Fletcher, M Truty, G Johnson… - 2018 - Soc Nuclear Med
1406 Purpose: For patients with pancreatic cancer, surgical resection remains the only
curative modality. Neo-adjuvant therapy (NAT) can potentially reduce tumor volume & treat …

Evaluation of fluorodeoxyglucose positron emission tomography scanning in the neoadjuvant therapy paradigm in pancreatic ductal adenocarcinoma

M Itchins, TC Chua, J Arena, NB Jamieson, CB Nahm… - Pancreas, 2020 - journals.lww.com
Objectives Little data exist on the utility of fluorodeoxyglucose positron emission tomography
(FDG-PET) in operable pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant …

18F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma

MR Benz, WR Armstrong, F Ceci… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The purpose of this study was to evaluate 18F-FDG PET/CT as an early and late interim
imaging biomarker in patients with pancreatic ductal adenocarcinoma who undergo first-line …

Prediction of local tumor control and recurrence‐free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy

H Suto, K Okano, M Oshima, Y Ando… - Journal of Surgical …, 2022 - Wiley Online Library
Abstract Background and Objectives There is little data on the correlation between the
reduction in fluorodeoxyglucose positron emission tomography (FDG‐PET) radioactive …